Olivier Ingster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olivier Ingster has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Abdel-Rahmène Azzouzi
Service d'urologie, CHU Angers, 4, rue Larrey, 49100, Angers, France
1 shared publication - Albert David
CHU Nantes, Service de Génétique Médicale Nantes France
1 shared publication - Aurelien de Reynies
Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre Le Cancer, Paris, France
1 shared publication - Brigitte Gilbert-Dussardier
Service de Génétique Médicale, Hôpital Jean Bernard, Poitiers, France
1 shared publication - Catherine Dugast
10Centre Eugène-Marquis, Rue de la Bataille Flandre-Dunkerque, Rennes 35042, France
1 shared publication - D. Farges
Département de génétique, CHU Angers, 4, rue Larrey, 49100, Angers, France
1 shared publication
Latest Publications
- 1 September 2020
- Published by Elsevier in Progrès en Urologie
- Vol. 30 (10) , 500-506
Prévalence de la sclérose tubéreuse de Bourneville chez des patients pris en charge pour un angiomyolipome rénal
- 1 September 2020
- Published by Elsevier in Progrès en Urologie
- Vol. 30 (10) , 500-506
Prévalence de la sclérose tubéreuse de Bourneville chez des patients pris en charge pour un angiomyolipome rénal
- Open Access
- 16 August 2010
- Published by Springer Nature in Breast Cancer Research
- Vol. 12 (4) , R63
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
Introduction: Breast carcinoma is the main malignant tumor occurring in patients with Cowden disease, a cancer-prone syndrome caused by germline mutation of the tumor suppressor gene PTEN characterized by the occurrence throughout life of hyperplastic, hamartomatous and malignant growths affecting various organs. The absence of known histological features for breast cancer arising in a PTEN-mutant background prompted us to explore them for potential new markers. Methods: We first performed a microarray study of three tumors from patients with Cowden disease in the context of a transcriptomic study of 74 familial breast cancers. A subsequent histological and immunohistochemical study including 12 additional cases of Cowden disease breast carcinomas was performed to confirm the microarray data. Results: Unsupervised clustering of the 74 familial tumors followed the intrinsic gene classification of breast cancer except for a group of five tumors that included the three Cowden tumors. The gene expression profile of the Cowden tumors shows considerable overlap with that of a breast cancer subgroup known as molecular apocrine breast carcinoma, which is suspected to have increased androgenic signaling and shows frequent ERBB2 amplification in sporadic tumors. The histological and immunohistochemical study showed that several cases had apocrine histological features and expressed GGT1, which is a potential new marker for apocrine breast carcinoma. Conclusions: These data suggest that activation of the ERBB2-PI3K-AKT pathway by loss of PTEN at early stages of tumorigenesis promotes the formation of breast tumors with apocrine features.
- 16 August 2010
- Published by Springer Nature in Breast Cancer Research
- Vol. 12 (4) , R63
Open AccessMolecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
Introduction: Breast carcinoma is the main malignant tumor occurring in patients with Cowden disease, a cancer-prone syndrome caused by germline mutation of the tumor suppressor gene PTEN characterized by the occurrence throughout life of hyperplastic, hamartomatous and malignant growths affecting various organs. The absence of known histological features for breast cancer arising in a PTEN-mutant background prompted us to explore them for potential new markers. Methods: We first performed a microarray study of three tumors from patients with Cowden disease in the context of a transcriptomic study of 74 familial breast cancers. A subsequent histological and immunohistochemical study including 12 additional cases of Cowden disease breast carcinomas was performed to confirm the microarray data. Results: Unsupervised clustering of the 74 familial tumors followed the intrinsic gene classification of breast cancer except for a group of five tumors that included the three Cowden tumors. The gene expression profile of the Cowden tumors shows considerable overlap with that of a breast cancer subgroup known as molecular apocrine breast carcinoma, which is suspected to have increased androgenic signaling and shows frequent ERBB2 amplification in sporadic tumors. The histological and immunohistochemical study showed that several cases had apocrine histological features and expressed GGT1, which is a potential new marker for apocrine breast carcinoma. Conclusions: These data suggest that activation of the ERBB2-PI3K-AKT pathway by loss of PTEN at early stages of tumorigenesis promotes the formation of breast tumors with apocrine features.